Unbiased AI-powered news
8 stories related to this topic, newest first.
zerohedge.comU.S. equity futures opened mixed Tuesday. Technology shares declined after Samsung Electronics reported preliminary second-quarter results and a Chinese firm disclosed plans for a new AI chip.
Substrate placeholder — needs reviewEthics filings show President Trump reported securities transactions valued between $220 million and $750 million during the first quarter of 2026. The filings include major trades linked to top U.S. companies and index funds. The disclosures cover activity from January through M…
Japan TimesThe Nikkei 225 ended Friday at 62,713.65 after hitting a record 63,091.14 the previous day. U.S. stocks retreated from record highs amid mixed signals on renewed U.S.-Iran peace talks and volatile oil prices. Toyota forecast an abrupt profit drop citing Iran-related factors, send…
Advanced Micro Devices reported first-quarter revenue of $10.25 billion, beating estimates amid 38% year-over-year growth driven by data centers. Shares of AMD, Intel, and Micron rose sharply, while Super Micro Computer and Arista Networks saw mixed after-hours moves. Major U.S.…
investors.comU.S. stock futures displayed mixed movements in pre-market trading on April 23, 2026. ServiceNow shares fell 13% due to delays in deal closings caused by a geopolitical conflict, impacting subscription revenue growth. IBM shares dropped 8% following results that exceeded expectat…
koreaherald.comGlobal stock markets, including those in the US, Taiwan, and South Korea, have shown gains nearly two months after the start of the conflict in Iran. The rally occurs amid ongoing geopolitical tensions. This development was reported by @business.
Substrate placeholder — needs reviewU.S. stock futures fell in pre-market trading on April 20, 2026, with the Nasdaq and Russell 2000 showing notable declines. Marvell shares rose on reports of talks with Google for new AI chips, while other companies like NXST and ASTS saw significant drops amid merger rulings and…
Substrate placeholder — needs reviewShares of Alamar Biosciences Inc. climbed 33% on Friday following the medical device maker's initial public offering that raised $191 million in the United States. The IPO was upsized and priced at the top of a marketed range. @business reported the details of the offering and sh…